bpc 157 vs tesamorelin tirzepatide Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent Quantity:1 pair Predrag Sikirić has been Vitamin B5

bpc 157 vs tesamorelin tirzepatide Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent Quantity:1 pair Predrag Sikirić has been Vitamin B5

Predrag Sikirić has been working on BPC-157 since the 1990s & says excitement over the peptide's possible therapeutic effects wasn't unexpected. Yet, media interest hasn't translated into funding to help put BPC-157

The peptide may improve chronic conditions to 70 to 90 percent of baseline rather than complete resolution

Vitamin B5

Quantity:1 pair

(Source of Km-based allometric scaling methodology.) US FDA